Double-Blind Test of Metronidazole and Tinidazole in the Treatment of Asymptomatic Entamoeba histolytica and Entamoeba hartmanni Carriers

Rupert Spillmann Tulane University International Center for Medical Research, Parasitology Section, Universidad del Valle Medical School, Apartado Aereo 5390, Cali, Colombia

Search for other papers by Rupert Spillmann in
Current site
Google Scholar
PubMed
Close
,
Stephen C. Ayala Tulane University International Center for Medical Research, Parasitology Section, Universidad del Valle Medical School, Apartado Aereo 5390, Cali, Colombia

Search for other papers by Stephen C. Ayala in
Current site
Google Scholar
PubMed
Close
, and
Carmen Elena de Sanchez Tulane University International Center for Medical Research, Parasitology Section, Universidad del Valle Medical School, Apartado Aereo 5390, Cali, Colombia

Search for other papers by Carmen Elena de Sanchez in
Current site
Google Scholar
PubMed
Close
Restricted access

One hundred and fifteen persons with asymptomatic Entamoeba histolytica or E. hartmanni infection, or both, were given metronidazole (750 mg three times daily for 5 days), tinidazole (1 g twice daily on 2 consecutive days), or a starch placebo. Three posttreatment stools were examined in the 2 weeks following initiation of treatment. Cysts of E. histolytica reappeared in the stools of 37% of 30 given metronidazole, 62% of 34 given tinidazole, and 70% of 31 given placebo. Cysts of E. hartmanni reappeared in the stools of 46% of 24 given metronidazole, 69% of 16 given tinidazole, and 90% of 10 given placebo. Rapid absorption and short duration of treatment make both drugs ineffective for the treatment of ameba carriers.

Author Notes

Past two years Past Year Past 30 Days
Abstract Views 1628 1031 120
Full Text Views 18 2 0
PDF Downloads 13 0 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save